UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

Cancer and metastasis reviews, 2020-12, Vol.39 (4), p.1029-1038

2020

Volltextzugriff (PDF)

Guest editorial/preface

Cancer and metastasis reviews, 2020-12, Vol.39 (4), p.1017-1017

Tímár, József

2020

Volltextzugriff (PDF)

On-Target Side Effects of Targeted Therapeutics of Cancer

Pathology oncology research, 2022-09, Vol.28, p.1610694-1610694

2022

Volltextzugriff (PDF)

Metastatic Progression of Human Melanoma

Cancers, 2023-02, Vol.15 (4), p.1225

2023

Volltextzugriff (PDF)

Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium

British journal of pharmacology, 2024-08, Vol.181 (15), p.2387-2390

2024

Volltextzugriff (PDF)

The role of lipid signaling in the progression of malignant melanoma

Cancer and metastasis reviews, 2018-09, Vol.37 (2-3), p.245-255

2018

Volltextzugriff (PDF)

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries

Cancers, 2023-03, Vol.15 (6), p.1712

2023

Volltextzugriff (PDF)

NSCLC molecular testing in Central and Eastern European countries

BMC cancer, 2018-03, Vol.18 (1), p.269-269, Article 269

2018

Volltextzugriff (PDF)

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma

Cancers, 2021-11, Vol.13 (23), p.5984

2021

Volltextzugriff (PDF)

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

NPJ precision oncology, 2021-06, Vol.5 (1), p.55-55, Article 55

2021

Volltextzugriff (PDF)

EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy

Cancers, 2020-03, Vol.12 (3), p.614

2020

Volltextzugriff (PDF)

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study

Lung cancer (Amsterdam, Netherlands), 2018-12, Vol.126, p.139-148

2018

Volltextzugriff (PDF)

Selective Inhibition of HIF1α Expression by ZnSO4 Has Antitumoral Effects in Human Melanoma

Pathology oncology research, 2020-04, Vol.26 (2), p.673-679

2020

Volltextzugriff (PDF)

A New Mechanism for Pillar Formation during Tumor-Induced Intussusceptive Angiogenesis

The American journal of pathology, 2011-09, Vol.179 (3), p.1573-1585

2011

Volltextzugriff (PDF)

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

Cancers, 2019-10, Vol.11 (10), p.1514

2019

Volltextzugriff (PDF)

Molecular testing in lung cancer in the era of precision medicine

Translational lung cancer research, 2014-10, Vol.3 (5), p.291-300

2014

Volltextzugriff (PDF)

Prognostic Impact of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratio, in Patients with Rectal Cancer: A Retrospective Study of 1052 Patients

Journal of personalized medicine, 2020-10, Vol.10 (4), p.173

2020

Volltextzugriff (PDF)

Development of Arterial Blood Supply in Experimental Liver Metastases

The American journal of pathology, 2009-08, Vol.175 (2), p.835-843

2009

Volltextzugriff (PDF)

Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK

Frontiers in oncology, 2017-05, Vol.7, p.95-95

2017

Volltextzugriff (PDF)

Minimal requirements for the molecular testing of lung cancer

Translational lung cancer research, 2014-10, Vol.3 (5), p.301-304

2014

Volltextzugriff (PDF)

Abstract LB220: Farnesyltransferase inhibitors show synergistic anticancer effects in combination with novel KRAS G12C inhibitors

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB220-LB220

2024

Volltextzugriff (PDF)

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

Scientific reports, 2017-01, Vol.7 (1), p.39721-39721, Article 39721

2017

Volltextzugriff (PDF)

Alteration of mutant allele frequency in visceral metastases of melanoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21528-e21528

2018

Volltextzugriff (PDF)

EGFR protein expression of the metastatic colorectal cancer as a prognostic/predictive factor for anti-EGFR antibody therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15548-e15548

2018

Volltextzugriff (PDF)

Abstract 3831: Oncogenic BRAF and concomitant RAS or PTENPI3K mutations determine together the response to RASRAFPI3K signaling network inhibition

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3831-3831

2016

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Aktive Filter

ThemaAged

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(152)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

Guest editorial/preface

On-Target Side Effects of Targeted Therapeutics of Cancer

Metastatic Progression of Human Melanoma

Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium

The role of lipid signaling in the progression of malignant melanoma

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries

NSCLC molecular testing in Central and Eastern European countries

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study

Selective Inhibition of HIF1α Expression by ZnSO4 Has Antitumoral Effects in Human Melanoma

A New Mechanism for Pillar Formation during Tumor-Induced Intussusceptive Angiogenesis

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

Molecular testing in lung cancer in the era of precision medicine

Prognostic Impact of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratio, in Patients with Rectal Cancer: A Retrospective Study of 1052 Patients

Development of Arterial Blood Supply in Experimental Liver Metastases

Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK

Minimal requirements for the molecular testing of lung cancer

Abstract LB220: Farnesyltransferase inhibitors show synergistic anticancer effects in combination with novel KRAS G12C inhibitors

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

Alteration of mutant allele frequency in visceral metastases of melanoma

EGFR protein expression of the metastatic colorectal cancer as a prognostic/predictive factor for anti-EGFR antibody therapy

Abstract 3831: Oncogenic BRAF and concomitant RAS or PTENPI3K mutations determine together the response to RASRAFPI3K signaling network inhibition

Aktive Filter

Suchergebnisse filtern